Kolexia
Giraudier Stephane Hématologie
Giraudier Stephane
Hématologie
Hôpital Saint-Louis
Paris, France
149 Activités
20 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Syndromes myéloprolifératifs Leucémies Myélofibrose primitive Leucémie myéloïde chronique BCR-ABL positive Leucémie myéloïde Thrombocytose Thrombocytémie essentielle Polyglobulie primitive essentielle Polyglobulie

Collaborateurs

Voir plus
Kiladjian Jean-Jacques
Kiladjian Jean-Jacques
Hôpital Saint-Louis, Paris, France
Cassinat Bruno
Cassinat Bruno
Hôpital Saint-Louis, Paris, France
Maslah Nabih
Maslah Nabih
Hôpital Saint-Louis, Paris, France
Legros Laurence
Legros Laurence
Hôpital Paul Brousse, Villejuif, France

Industries

Voir plus
Novartis
5 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
Haematologica   08 février 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.
American journal of hematology   26 janvier 2024
Genomic and functional impact of Trp53 inactivation in JAK2V617F myeloproliferative neoplasms.
Blood cancer journal   04 janvier 2024
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.
Leukemia   27 décembre 2023
Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera
65th ASH Annual Meeting Abstracts   02 novembre 2023
Clinical features and genomic landscape of myeloproliferative neoplasm (MPN) patients with autoimmune and inflammatory diseases (AID).
Leukemia   11 juillet 2023
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
Leukemia   26 avril 2023
Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape.
Leukemia   31 mars 2023
Reduced murine double minute 2 and 4 protein, but not messenger RNA, expression is associated with more severe disease in myelodysplastic syndromes and acute myeloblastic leukaemia.
British journal of haematology   22 décembre 2022